Dimerix Limited
Dimerix Limited (DXB.AX) Financial Performance & Income Statement Overview
Analyze Dimerix Limited (DXB.AX) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Dimerix Limited (DXB.AX) Income Statement & Financial Overview
Review Dimerix Limited DXB.AX income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $287450.00 | $450418.00 | $133060.00 | $8.98M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $287450.00 | $450418.00 | $133060.00 | $8.98M |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $11.37M | $16.02M | $5.08M | $11.89M |
| SG&A Expenses | $2.02M | $2.73M | $1.82M | $1.25M |
| Operating Expenses | $13.38M | $18.75M | $6.90M | $13.14M |
| Total Costs & Expenses | $13.38M | $18.75M | $6.90M | $13.14M |
| Interest Income | $0.00 | $138035.00 | $37977.00 | $10240.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $3137.00 | $4026.00 | $2247.00 | $2778.00 |
| EBITDA | -$13.09M | -$10.36M | -$6.71M | -$4.19M |
| EBITDA Ratio | -$45.55 | -$23.001 | -$50.42 | -$0.47 |
| Operating Income | -$13.10M | -$18.30M | -$6.76M | -$13.14M |
| Operating Income Ratio | -$45.56 | -$40.62 | -$50.83 | -$1.46 |
| Other Income/Expenses (Net) | $189170.00 | $7.89M | $90463.00 | $8.94M |
| Income Before Tax | -$12.91M | -$10.40M | -$6.67M | -$4.19M |
| Income Before Tax Ratio | -$44.90 | -$23.09 | -$50.15 | -$0.47 |
| Income Tax Expense | $0.00 | $0.00 | $52486.00 | $8.93M |
| Net Income | -$12.91M | -$10.40M | -$6.67M | -$4.19M |
| Net Income Ratio | -$44.90 | -$23.09 | -$50.15 | -$0.47 |
| EPS | -$0.02 | -$0.02 | -$0.02 | -$0.01 |
| Diluted EPS | -$0.02 | -$0.02 | -$0.02 | -$0.01 |
| Weighted Avg Shares Outstanding | $554.76M | $500.10M | $405.74M | $336.72M |
| Weighted Avg Shares Outstanding (Diluted) | $554.76M | $500.08M | $405.74M | $336.72M |
The company's financials show resilient growth, with revenue advancing from $8.98M in Q4 2023 to $287450.00 in Q2 2025. Gross profit remained healthy with margins at 100% in Q2 2025 compared to 100% in Q4 2023. Operating income hit -$13.10M last quarter, sustaining a consistent -4556% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$13.09M. Net income dropped to -$12.91M, while earnings per share reached -$0.02. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan